Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis

被引:6
|
作者
Hubl, Daniela [1 ]
Michel, Chantal [2 ]
Schultze-Lutter, Frauke [3 ]
Hauf, Martinus [4 ]
Schimmelmann, Benno G. [2 ,5 ]
Kaess, Michael [2 ,6 ]
Kindler, Jochen [2 ]
机构
[1] Univ Bern, Univ Hosp Psychiat & Psychotherapy, Translat Res Ctr, Bern, Switzerland
[2] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland
[3] Heinrich Heine Univ, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[4] Univ Bern, Support Ctr Adv Neuroimaging SCAN, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland
[5] Univ Hosp Hamburg Eppendorf, Univ Hosp Child & Adolescent Psychiat, Hamburg, Germany
[6] Univ Hosp Heidelberg, Ctr Psychosocial Med, Dept Child & Adolescent Psychiat, Sect Translat Psychobiol Child & Adolescent Psych, Heidelberg, Germany
关键词
Basic symptoms; first-episode psychosis; gray matter volume; psychosis risk; ultra-high risk; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; CEREBRAL-BLOOD-FLOW; ULTRA-HIGH RISK; PROGRESSIVE REDUCTION; CORTICAL THICKNESS; EPA GUIDANCE; SCHIZOPHRENIA; PREDICTION; BRAIN; ABNORMALITIES;
D O I
10.1017/S0033291720001282
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Clinical high-risk (CHR) for psychosis is indicated by ultra-high risk (UHR) and basic symptom (BS) criteria; however, conversion rates are highest when both UHR and BS criteria are fulfilled (UHR&BS). While BSs are considered the most immediate expression of neurobiological aberrations underlying the development of psychosis, research on neurobiological correlates of BS is scarce. Methods We investigated gray matter volumes (GMV) of 20 regions of interest (ROI) previously associated with UHR criteria in 90 patients from the Bern early detection service: clinical controls (CC), first-episode psychosis (FEP), UHR, BS and UHR&BS. We expected lowest GMV in FEP and UHR&BS, and highest volume in CC with UHR and BS in-between. Results Significantly, lower GMV was detected in FEP and UHR&BS patients relative to CC with no other significant between-group differences. When ROIs were analyzed separately, seven showed a significant group effect (FDR corrected), with five (inferior parietal, medial orbitofrontal, lateral occipital, middle temporal, precuneus) showing significantly lower GM volume in the FEP and/or UHR&BS groups than in the CC group (Bonferroni corrected). In the CHR group, only COGDIS scores correlated negatively with cortical volumes. Conclusions This is the first study to demonstrate that patients who fulfill both UHR and BS criteria - a population that has been associated with higher conversion rates - exhibit more severe GMV reductions relative to those who satisfy BS or UHR criteria alone. This result was mediated by the BS in the UHR&BS group, as only the severity of BS was linked to GMV reductions.
引用
收藏
页码:2666 / 2674
页数:9
相关论文
共 50 条
  • [21] Structure of positive psychotic symptoms in individuals at clinical high risk for psychosis
    Azis, Matilda
    Rouhakhtar, Pamela Rakhshan
    Schiffman, Jason E.
    Ellman, Lauren M.
    Strauss, Gregory P.
    Mittal, Vijay A.
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (03) : 505 - 512
  • [22] Self-esteem and Symptoms in Individuals at Clinical High Risk for Psychosis
    Benavides, Caridad
    Brucato, Gary
    Kimhy, David
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2018, 206 (06) : 433 - 438
  • [23] Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis
    Kindler, Jochen
    Schultze-Lutter, Frauke
    Hauf, Martinus
    Dierks, Thomas
    Federspiel, Andrea
    Walther, Sebastian
    Schimmelmann, Benno G.
    Hubl, Daniela
    SCHIZOPHRENIA BULLETIN, 2018, 44 (01) : 182 - 192
  • [24] Altered Thalamo-Cortical White Matter Connectivity: Probabilistic Tractography Study in Clinical-High Risk for Psychosis and First-Episode Psychosis
    Cho, Kang Ik K.
    Shenton, Martha E.
    Kubicki, Marek
    Jung, Wi Hoon
    Lee, Tae Young
    Yun, Je-Yeon
    Kim, Sung Nyun
    Kwon, Jun Soo
    SCHIZOPHRENIA BULLETIN, 2016, 42 (03) : 723 - 731
  • [25] Negative symptoms in individuals at clinical high risk of psychosis
    Piskulic, Danijela
    Addington, Jean
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    Heinssen, Robert
    Perkins, Diana O.
    Seidman, Larry J.
    Tsuang, Ming T.
    Walker, Elaine F.
    Woods, Scott W.
    McGlashan, Thomas H.
    PSYCHIATRY RESEARCH, 2012, 196 (2-3) : 220 - 224
  • [26] Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis
    Schlosser, Danielle A.
    Campellone, Timothy R.
    Biagianti, Bruno
    Delucchi, Kevin L.
    Gard, David E.
    Fulford, Daniel
    Stuart, Barbara K.
    Fisher, Melissa
    Loewy, Rachel L.
    Vinogradov, Sophia
    SCHIZOPHRENIA RESEARCH, 2015, 169 (1-3) : 204 - 208
  • [27] Structural Brain Volumes of Individuals at Clinical High Risk for Psychosis: A Meta-analysis
    Vissink, Conrad E.
    Winter-van Rossum, Inge
    Cannon, Tyrone D.
    Fusar-Poli, Paolo
    Kahn, Rene S.
    Bossong, Matthijs G.
    BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2022, 2 (02): : 147 - 152
  • [28] Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis
    Buchy, Lisa
    Mathalon, Daniel H.
    Cannon, Tyrone D.
    Cadenhead, Kristin S.
    Cornblatt, Barbara A.
    McGlashan, Thomas H.
    Perkins, Diana O.
    Seidman, Larry J.
    Tsuang, Ming T.
    Walker, Elaine F.
    Woods, Scott W.
    Bearden, Carrie E.
    Addington, Jean
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2016, 254 : 3 - 9
  • [29] White matter microstructure and the clinical risk for psychosis: A diffusion tensor imaging study of individuals with basic symptoms and at ultra-high risk
    Smigielski, Lukasz
    Stampfli, Philipp
    Wotruba, Diana
    Buechler, Roman
    Sommer, Stefan
    Gerstenberg, Miriam
    Theodoridou, Anastasia
    Walitza, Susanne
    Rossler, Wulf
    Heekeren, Karsten
    NEUROIMAGE-CLINICAL, 2022, 35
  • [30] Substance use and regional gray matter volume in individuals at high risk of psychosis
    Stone, James M.
    Bhattacharyya, Sagnik
    Barker, Gareth J.
    McGuire, Philip K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (02) : 114 - 122